Literature DB >> 9598882

Sense of coherence--a protective factor for depression in rheumatoid arthritis.

S Büchi1, T Sensky, S Allard, T Stoll, U Schnyder, R Klaghofer, C Buddeberg.   

Abstract

OBJECTIVE: A stress-vulnerability model of depression was investigated in patients with rheumatoid arthritis (RA). Antonovsky's Sense of Coherence (SOC) was examined as a factor protecting against depression.
METHOD: Relationships between sociodemographic factors, disease activity, functional impairment, pain, depression, and SOC were assessed using multivariate methods in a cross sectional sample of 89 consecutive outpatients with RA.
RESULTS: Increased prevalence of depression was associated with low SOC and high self-rated pain levels, but not with other factors assessed. By multiple regression analysis, independent contributions to depression were observed for SOC (23% of variance) and for pain (24% of variance), but not functional impairment or disease activity.
CONCLUSION: Comprehensive models of adjustment in RA need to include protective factors such as SOC, in addition to pain and other pathological variables. SOC may be helpful in identifying individuals with RA who are particularly vulnerable to depression, who may be helped by focused psychological interventions such as cognitive therapy.

Entities:  

Mesh:

Year:  1998        PMID: 9598882

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  13 in total

1.  Sense of coherence buffers relationships of chronic stress with fasting glucose levels.

Authors:  J Zhang; P P Vitaliano; S K Lutgendorf; J M Scanlan; M V Savage
Journal:  J Behav Med       Date:  2001-02

2.  Relationships between health domains and sense of coherence: a two-year cross-lagged study in patients with chronic illness.

Authors:  Marijke Veenstra; Torbjørn Moum; Espen Røysamb
Journal:  Qual Life Res       Date:  2005-08       Impact factor: 4.147

Review 3.  Validity of Antonovsky's sense of coherence scale: a systematic review.

Authors:  Monica Eriksson; Bengt Lindström
Journal:  J Epidemiol Community Health       Date:  2005-06       Impact factor: 3.710

Review 4.  Salutogenesis.

Authors:  Bengt Lindström; Monica Eriksson
Journal:  J Epidemiol Community Health       Date:  2005-06       Impact factor: 3.710

Review 5.  Antonovsky's sense of coherence scale and the relation with health: a systematic review.

Authors:  Monica Eriksson; Bengt Lindström
Journal:  J Epidemiol Community Health       Date:  2006-05       Impact factor: 3.710

6.  Measurement properties of the 13-item sense of coherence scale using Rasch analysis.

Authors:  Marie Holmefur; Kay Sundberg; Lena Wettergren; Ann Langius-Eklöf
Journal:  Qual Life Res       Date:  2014-11-27       Impact factor: 4.147

7.  Psychosocial problems among newly diagnosed rheumatoid arthritis patients.

Authors:  C Gåfvels; M Hägerström; B Nordmark; P E Wändell
Journal:  Clin Rheumatol       Date:  2011-11-18       Impact factor: 2.980

8.  A population-based study of depressive symptoms in multiple sclerosis in Stockholm county: association with functioning and sense of coherence.

Authors:  K Gottberg; U Einarsson; S Fredrikson; L von Koch; L W Holmqvist
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-07-17       Impact factor: 10.154

9.  Sense of coherence and self-sacrificing defense style as predictors of psychological distress and quality of life in rheumatoid arthritis: a 5-year prospective study.

Authors:  Panagiota Goulia; Paraskevi V Voulgari; Niki Tsifetaki; Elias Andreoulakis; Alexandros A Drosos; André F Carvalho; Thomas Hyphantis
Journal:  Rheumatol Int       Date:  2014-09-21       Impact factor: 2.631

10.  The influence of cancer-related distress and sense of coherence on anxiety and depression in patients with hereditary cancer: a study of patients' sense of coherence 6 months after genetic counseling.

Authors:  Elen Siglen; Cathrine Bjorvatn; Lars Fredrik Engebretsen; Gunilla Berglund; Gerd Karin Natvig
Journal:  J Genet Couns       Date:  2007-08-12       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.